Skip to main content
Fig. 2 | Gut Pathogens

Fig. 2

From: Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial

Fig. 2

Antimicrobial resistance profile in children receiving either placebo or azithromycin treatment. a The proportion of macrolide-resistant bacteria at 24-month follow-up in children receiving either placebo (blue) or azithromycin (red). b Univariate analysis of antibiotic classes with increased evidence of resistance (linear regression coefficient > 0) or decreased evidence of resistance (linear regression coefficient < 0) after azithromycin treatment. Flat-headed lines indicate the standard error around the coefficient. c The proportion of macrolide-resistant bacteria during 24-month follow-up in children receiving azithromycin 6 months or 12–24 months previously. P-values were considered significant at < 0.05 and are denominated as follows: ***p < 0.001

Back to article page

Gut Pathogens

ISSN: 1757-4749